Stocks Climb on Strength in Consumer Spending and Tame Inflation

US equities are broadly higher today, driven by stronger-than-expected August personal spending and core PCE inflation data meeting forecasts, reinforcing expectations for continued Fed rate cuts, with markets pricing an 86% chance of a 25bp cut at the next FOMC meeting. Sector-specific gains include semiconductor stocks on reports of a potential Trump administration plan to boost domestic chip manufacturing, and pharmaceutical companies, which Jeffries views as beneficiaries despite proposed tariffs due to their U.S. production presence. This positive sentiment is further supported by rising corporate earnings expectations for Q3, though a potential government shutdown on October 1 remains a key risk.

Analysis

US equity markets are exhibiting broad strength, propelled by a favorable combination of robust macroeconomic data and benign inflation metrics. August personal spending surged +0.6% month-over-month, its most substantial increase in five months and ahead of the +0.5% consensus, signaling sustained consumer resilience. Concurrently, the core Personal Consumption Expenditures (PCE) price index, the Federal Reserve's preferred inflation gauge, aligned perfectly with expectations, rising +0.2% m/m and +2.9% y/y. This in-line inflation reading reinforces market expectations for further monetary easing, with federal funds futures pricing an 86% probability of a 25 basis point rate reduction at the October FOMC meeting. This dovish sentiment is further supported by upwardly revised Q3 earnings growth expectations for S&P 500 companies, now at +6.9%. Sector-specific catalysts are also driving performance; semiconductor stocks, including GlobalFoundries (GFS, +9%) and Intel (INTC, +4%), rallied on reports of a potential administration plan to bolster domestic chip manufacturing. Similarly, pharmaceutical firms like Eli Lilly (LLY, +1%) advanced after an analyst note framed proposed tariffs as a net positive for companies with significant US production. However, a key macro risk looms with a potential US government shutdown on October 1, and company-specific weaknesses are apparent in names like Concentrix (CNXC), which fell over 10% on poor guidance, and Costco (COST), which declined on a slight comparable sales miss.

Key Decisions for Investors

• Consider overweighting US-based semiconductor manufacturers like GlobalFoundries (GFS) and Intel (INTC), as potential government initiatives to onshore chip production represent a significant sector-specific tailwind.
• Evaluate US-domiciled pharmaceutical and industrial companies, such as Eli Lilly (LLY), Merck (MRK), and Paccar (PCAR), which are positioned to benefit from policy shifts favoring domestic production and tariffs on foreign goods.
• Maintain a moderately bullish stance on the broader market, supported by strong consumer data and dovish Fed expectations, but hedge or set stop-losses to mitigate the near-term risk of a potential US government shutdown.
• Investors should scrutinize companies exhibiting weakness despite the positive market, such as Concentrix (CNXC) and Costco (COST), as their underperformance on weak guidance and sales misses may indicate fundamental issues rather than just market noise.